VIRX Annual Working Capital
$16.59 M
-$67.14 M-80.19%
31 December 2023
Summary:
As of January 23, 2025, VIRX annual working capital is $16.59 million, with the most recent change of -$67.14 million (-80.19%) on December 31, 2023. During the last 3 years, it has fallen by -$24.32 million (-59.45%). VIRX annual working capital is now -82.75% below its all-time high of $96.19 million, reached on December 31, 2021.VIRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIRX Quarterly Working Capital
-$6.77 M
-$9.19 M-379.72%
30 September 2024
Summary:
As of January 23, 2025, VIRX quarterly working capital is -$6.77 million, with the most recent change of -$9.19 million (-379.72%) on September 30, 2024. Over the past year, it has dropped by -$23.36 million (-140.82%). VIRX quarterly working capital is now -105.37% below its all-time high of $126.04 million, reached on March 31, 2021.VIRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.2% | -140.8% |
| 3 y3 years | -59.5% | -140.8% |
| 5 y5 years | -59.5% | -140.8% |
VIRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.8% | at low | -107.0% | at low |
| 5 y | 5-year | -82.8% | at low | -105.4% | at low |
| alltime | all time | -82.8% | at low | -105.4% | at low |
Viracta Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$6.77 M(-379.7%) |
| June 2024 | - | $2.42 M(-77.4%) |
| Mar 2024 | - | $10.70 M(-35.5%) |
| Dec 2023 | $16.59 M(-80.2%) | $16.59 M(-40.8%) |
| Sept 2023 | - | $28.01 M(-52.8%) |
| June 2023 | - | $59.34 M(-17.3%) |
| Mar 2023 | - | $71.76 M(-14.3%) |
| Dec 2022 | $83.74 M | $83.74 M(+19.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $70.29 M(-11.2%) |
| June 2022 | - | $79.14 M(-9.7%) |
| Mar 2022 | - | $87.61 M(-8.9%) |
| Dec 2021 | $96.19 M(+135.1%) | $96.19 M(-9.1%) |
| Sept 2021 | - | $105.85 M(-10.4%) |
| June 2021 | - | $118.19 M(-6.2%) |
| Mar 2021 | - | $126.04 M(+208.1%) |
| Dec 2020 | $40.91 M | $40.91 M |
FAQ
- What is Viracta Therapeutics annual working capital?
- What is the all time high annual working capital for Viracta Therapeutics?
- What is Viracta Therapeutics annual working capital year-on-year change?
- What is Viracta Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly working capital year-on-year change?
What is Viracta Therapeutics annual working capital?
The current annual working capital of VIRX is $16.59 M
What is the all time high annual working capital for Viracta Therapeutics?
Viracta Therapeutics all-time high annual working capital is $96.19 M
What is Viracta Therapeutics annual working capital year-on-year change?
Over the past year, VIRX annual working capital has changed by -$67.14 M (-80.19%)
What is Viracta Therapeutics quarterly working capital?
The current quarterly working capital of VIRX is -$6.77 M
What is the all time high quarterly working capital for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly working capital is $126.04 M
What is Viracta Therapeutics quarterly working capital year-on-year change?
Over the past year, VIRX quarterly working capital has changed by -$23.36 M (-140.82%)